Your browser doesn't support javascript.
loading
An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy.
Feng, Mingtao; Cui, Huanhuan; Tu, Wenjing; Li, Liangdong; Gao, Yang; Chen, Lei; Li, Deheng; Chen, Xin; Xu, Fengfeng; Zhou, Changshuai; Cao, Yiqun.
  • Feng M; Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Cui H; Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Tu W; Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Li L; Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Gao Y; Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Chen L; Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Li D; Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Chen X; Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Xu F; Department of Neurosurgery, Naval Medical Center of PLA, Shanghai, China.
  • Zhou C; Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Cao Y; Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Front Genet ; 13: 975381, 2022.
Article en En | MEDLINE | ID: mdl-36105075